PACB — Pacific Biosciences Of California Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapValue Trap

Market Cap
$415.33m
Enterprise Value
$677.14m
Revenue
$200.52m

Annual balance sheet for Pacific Biosciences Of California, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	49.1	319	1,044	772	631
Net Total Accounts Receivable
Net Total Receivables	15.3	16.8	24.2	18.8	36.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	81	356	1,101	852	742
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	62.9	54.9	79.1	81.3	69
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	148	414	2,007	1,767	1,746
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	49.2	38.5	71.7	263	95
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	93.1	78.5	1,216	1,204	1,045
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	54.9	335	791	563	701
Total Liabilities & Shareholders' Equity	148	414	2,007	1,767	1,746
Total Common Shares Outstanding